According to Market Research Future (MRFR), the global interventional neurology market is projected to grow significantly over the forecast period. The market held a valuation of USD 1832.6 million in 2017 and expected to rise from 2017 to 2023 (forecast period) at a CAGR of 7.8%.

Interventional neurology can be depicted as a specialty for the treatment of significant sicknesses of the cerebrum, spine, and neck through insignificantly obtrusive picture directed strategies. Significant infections treated with interventional nervous system specialists incorporate cerebral aneurysm, meningiomas, head and neck growths, ischemic strokes, intracranial atherosclerosis, spinal vascular abnormalities, and vertebral body cancers.

Market Dynamics

Increasing prevalence of neurological diseases is one of the primary factors driving the market for interventional neurology. Of the 1.2 million most commonly diagnosed adult-onset brain conditions, 21% and 51.3% are due to Alzheimer's disease and stroke, respectively. Several other factors, such as technological advancements, the existence of a large target patient population, favorable medical reimbursements, and increasing demand for effective neurovascular devices, are also expected to drive the growth of the market.

However, the lack of trained neurosurgeons and strict regulations may hinder the growth of the market over the forecast period.


The global interventional neurology market is segmented on disease pathology, product, end-user, and region.

By disease pathology, the market is segmented into arteriovenous malformation and fistulas, cerebral aneurysms, ischemic strokes, and others.

Result, the market is sectioned into aneurysm looping and embolization gadgets, cerebral inflatable angioplasty and stenting frameworks, support gadgets, and neurothrombectomy gadgets. The section for aneurysm looping and embolization gadgets is additionally ordered as embolic curls, fluid embolic specialists, and stream redirection gadgets. The portion for embolic curls incorporates covered separable loops and exposed separable curls. The fragment for cerebral inflatable angioplasty and stenting frameworks are additionally arranged as carotid course stents and embolic insurance frameworks. The portion for embolic security frameworks incorporates distal channel gadgets and inflatable impediment gadgets. The neurothrombectomy gadgets are additionally classified as clump recovery gadgets, pull and desire gadgets, and catches. The section for help gadgets is additionally delegated microcatheters and microguidewires.

Based on the end-user, the market is segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.

Region-wise, the global interventional neurology market is segmented into the four global regions, namely the Americas, Europe, the Asia Pacific, and the Middle East & African region.

Request Free Sample Copy at:

The Americas dominated the interventional neurology global market due to the involvement of major market players and the increasing geriatric population.

It was estimated that Europe was second in the global interventional neurology market in 2017. This can be due to growing investment in research and development. Increased participation of industry participants is also improving the interventional neurology industry. In 2018, for example, Rapid Medical announced the approval in the European Union of the CE Mark for its Tigertriever 13 stent retriever to treat ischemic stroke.

The Asia Pacific was also anticipated to be the fastest-growing region in 2017. Factors such as the rising healthcare sector, the growing penetration of market players in the region, and the increase in healthcare expenditure are driving regional markets in the Asia Pacific region. According to data presented by the Australian Institute of Health and Welfare in 2017, almost USD 181 billion is spent on health in Australia.

The Middle East and Africa had the lowest share in the global interventional neurology market due to the low per capita income, particularly in the African region. Development in this area is due to increasing cases of neurological conditions. Over the years, the burden of neurological disorders in the African region has increased. The annual incidence of stroke has been projected to be 316 per 100 000 in Africa.

Key Players

Some of the major participants in the global interventional neurology market are Boston Scientific Corporation, Abbott Laboratories, Johnson & Johnson, Stryker Corporation, Medtronic PLC, Merit Medical Systems, Terumo Corporation, Penumbra, Inc., Micropart Scientific Corporation, B. Braun Melungeon AG, Inc., W.L. Gore & Associates, Inc., Cook Medical, and others.

Browse Detailed TOC with COVID-19 Impact Analysis at:

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071